BACKGROUND: Present angiotensin-converting-enzyme inhibitor treatment fails to prevent progression of non-diabetic renal disease. We aimed to assess the efficac...
作者：国际循环网 发布于：2004-08-24
BACKGROUND: Most cardiovascular events associated with hypertension are complications of atherosclerosis. Some antihypertensive agents influence experimental mo...
作者：ZanchettiA，BondMG，HennigM 发布于：2004-08-24
BACKGROUND: Calcium antagonists are a first-line treatment for hypertension. The effectiveness of diltiazem， a non-dihydropyridine calcium antagonist， in redu...
BACKGROUND: Beta blockers reduce mortality in patients who have chronic heart failure， systolic dysfunction， and are on background treatment with diuretics an...
BACKGROUND: We investigated the effects of candesartan (an angiotensin II antagonist) alone， enalapril alone， and their combination on exercise tolerance， ve...
BACKGROUND. In patients with heart failure， activation of the renin-angiotensin system is common and has been postulated to provide a stimulus for further left...
ESC热评 | 刘少稳教授：房颤患者药物治..
ESC专访 | 老年心梗患者，基于生理学指..
ESC专访 | 临床实践中，冠状动脉疾病的..
再添力证：早期联合降脂治疗可显著改善..
京公网安备 11010502033353号 增值电信业务经营许可证:京ICP证150541号
